Send us a Message



Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   

CHEBI ONTOLOGY - ANNOTATIONS

The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.

Term:levonorgestrel
go back to main search page
Accession:CHEBI:6443 term browser browse the term
Definition:A terminal acetylenic compound that has formula C21H28O2.
Synonyms:exact_synonym: 17alpha-ethynyl-17beta-hydroxy-18a-homoestr-4-en-3-one
 related_synonym: (-)-13-Ethyl-17-hydroxy-18,19-dinor-17alpha-pregn-4-en-20-yn-3-one;   13-Ethyl-17-alpha-ethynyl-17-beta-hydroxy-4-gonen-3-one;   13-Ethyl-17-alpha-ethynylgon-4-en-17-beta-ol-3-one;   13-beta-Ethyl-17alpha-ethynyl-17beta-hydroxygon-4-en-3-one;   17-Ethynyl-18-methyl-19-nortestosterone;   17-alpha-Ethinyl-13-beta-ethyl-17-beta-hydroxy-4-estren-3-one;   17-alpha-Ethynyl-13-ethyl-19-nortestosterone;   17alpha-Ethynyl-13beta-ethyl-3-oxo-4-estren-17beta-ol;   17alpha-Ethynyl-17-hydroxy-18-methylestr-4-en-3-one;   17alpha-Ethynyl-18-homo-19-nortestosterone;   18-Methyl-17-alpha-ethynyl-19-nortestosterone;   18-Methylnorethisterone;   Formula=C21H28O2;   InChI=1S/C21H28O2/c1-3-20-11-9-17-16-8-6-15(22)13-14(16)5-7-18(17)19(20)10-12-21(20,23)4-2/h2,13,16-19,23H,3,5-12H2,1H3/t16-,17+,18+,19-,20-,21-/m0/s1;   InChIKey=WWYNJERNGUHSAO-XUDSTZEESA-N;   Jadelle;   Levonelle;   Levonova;   Microlut;   Microluton;   Microval;   Mirena;   NorLevo;   Plan B;   Postinor;   SMILES=[H][C@]12CCC(=O)C=C1CC[C@]1([H])[C@]2([H])CC[C@@]2(CC)[C@@]1([H])CC[C@@]2(O)C#C;   d(-)-Norgestrel;   levonorgestrelum
 xref: Beilstein:6067808;   CAS:6533-00-2;   CAS:797-63-7;   DrugBank:DB00367;   KEGG:C08149;   KEGG:C08153;   KEGG:D00950;   KEGG:D00954;   LIPID_MAPS_instance:LMST02030119
 xref_mesh: MESH:D016912
 xref: PDBeChem:NOG;   Patent:BE623844;   Patent:US3959322
 cyclic_relationship: is_enantiomer_of CHEBI:50900


show annotations for term's descendants           Sort by:
 
levonorgestrel term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Abcb1a ATP binding cassette subfamily B member 1A increases expression ISO Levonorgestrel results in increased expression of ABCB1 mRNA CTD PMID:15290871 NCBI chr 4:25,357,467...25,529,941
Ensembl chr 4:25,158,362...25,442,709
JBrowse link
G Abhd5 abhydrolase domain containing 5, lysophosphatidic acid acyltransferase multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of ABHD5 mRNA CTD PMID:19074003 NCBI chr 8:122,000,241...122,026,447
Ensembl chr 8:122,000,389...122,026,447
JBrowse link
G Ace2 angiotensin I converting enzyme 2 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of ACE2 mRNA CTD PMID:19074003 NCBI chr  X:30,293,597...30,340,961
Ensembl chr  X:30,293,589...30,340,977
JBrowse link
G Adgrf5 adhesion G protein-coupled receptor F5 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of ADGRF5 mRNA CTD PMID:19074003 NCBI chr 9:17,517,596...17,624,107
Ensembl chr 9:17,520,009...17,623,968
JBrowse link
G Adipoq adiponectin, C1Q and collagen domain containing multiple interactions ISO Norgestrel inhibits the reaction [[Dexamethasone co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of and results in increased secretion of ADIPOQ protein] CTD PMID:29782964 NCBI chr11:77,721,912...77,735,644
Ensembl chr11:77,721,912...77,735,564
JBrowse link
G Afg1l AFG1 like ATPase multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of AFG1L mRNA CTD PMID:19074003 NCBI chr20:45,798,344...45,967,997 JBrowse link
G Agt angiotensinogen multiple interactions ISO [Ethinyl Estradiol co-treated with Levonorgestrel] results in increased expression of AGT protein CTD PMID:17519148 NCBI chr19:52,529,139...52,549,618
Ensembl chr19:52,529,185...52,540,977
JBrowse link
G Ahctf1 AT hook containing transcription factor 1 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of AHCTF1 mRNA CTD PMID:19074003 NCBI chr13:91,481,932...91,536,391
Ensembl chr13:91,481,936...91,536,391
JBrowse link
G Akr1c3 aldo-keto reductase family 1, member C3 decreases activity ISO Levonorgestrel results in decreased activity of AKR1C3 protein CTD PMID:21182831 NCBI chr17:66,110,970...66,127,867
Ensembl chr17:66,110,963...66,127,873
JBrowse link
G Alms1 ALMS1, centrosome and basal body associated protein multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of ALMS1 mRNA CTD PMID:19074003 NCBI chr 4:118,125,581...118,226,005
Ensembl chr 4:118,125,607...118,226,005
JBrowse link
G Alpk2 alpha-kinase 2 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of ALPK2 mRNA CTD PMID:19074003 NCBI chr18:58,775,603...58,906,150
Ensembl chr18:58,775,605...58,906,258
JBrowse link
G Alpl alkaline phosphatase, biomineralization associated multiple interactions ISO VDR gene polymorphism affects the reaction [[Ethinyl Estradiol co-treated with Levonorgestrel] affects the expression of ALPL protein] CTD PMID:12521655 NCBI chr 5:149,951,397...150,006,424
Ensembl chr 5:149,951,409...150,006,446
JBrowse link
G Ammecr1 AMMECR nuclear protein 1 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of AMMECR1 mRNA CTD PMID:19074003 NCBI chr  X:106,465,982...106,571,382
Ensembl chr  X:106,466,699...106,571,487
JBrowse link
G Ankdd1a ankyrin repeat and death domain containing 1A multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of ANKDD1A mRNA CTD PMID:19074003 NCBI chr 8:66,017,571...66,043,738
Ensembl chr 8:66,017,773...66,042,651
JBrowse link
G Api5 apoptosis inhibitor 5 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of API5 mRNA CTD PMID:19074003 NCBI chr 3:80,378,100...80,403,267
Ensembl chr 3:80,378,096...80,403,264
JBrowse link
G Apob apolipoprotein B multiple interactions ISO [Ethinyl Estradiol co-treated with Levonorgestrel] results in increased expression of APOB protein CTD PMID:15769986 NCBI chr 6:30,844,386...30,883,983
Ensembl chr 6:30,844,368...30,892,497
JBrowse link
G Ar androgen receptor affects binding
multiple interactions
EXP
ISO
Levonorgestrel binds to AR protein
1-hydroxypyrene inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; 17 alpha-Hydroxyprogesterone Caproate inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; 17-alpha-Hydroxyprogesterone inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; 2,2',4,4'-tetrahydroxybenzophenone inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; 2,2'-bisphenol F inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; 2,2'-dihydroxy-6,6'-dinaphthyldisulfide inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; 2,2-bis(4-hydroxyphenyl)-1,1,1-trichloroethane inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; 2,4,6-triiodophenol inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; 2,5-di-tert-butylhydroquinone inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; 2-chloro-4-phenylphenol inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; 2-tert-butylhydroquinone inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; 2-tolidine inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; 3-iodo-2-propynylbutylcarbamate inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; 3-phenoxybenzylalcohol inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; 4,4'-dichlorodiphenyl sulfone inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; 4,4'-hexafluorisopropylidene diphenol inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; 4-cumylphenol inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; 4-phenylphenol inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; 4-tert-octylphenol inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; 7-dimethylamino-4-methylcoumarin inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; 9,10-Dimethyl-1,2-benzanthracene inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; 9-phenanthrol inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; [6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein; acetochlor inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; acetyl methyl tetramethyl tetralin inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; afimoxifene inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; alpha-isomethylionone inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; Apigenin inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; atraric acid inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; Azinphosmethyl inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; bicalutamide inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; bisphenol A inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; bromadiolone inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; bromuconazole inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; butylbenzyl phthalate inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; butylphen inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; Chlordecone inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; chlorobenzilate inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; chloroxylenol inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; Clomiphene inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; clorophene inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; Coumaphos inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; Cyproterone Acetate inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; d,d-T80-prallethrin inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; DDT inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; Dehydroepiandrosterone inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; devrinol inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; di-n-pentyl phthalate inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; diallyl phthalate inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; Dibutyl Phthalate inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; Dichlorodiphenyl Dichloroethylene inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; Dichlorodiphenyldichloroethane inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; dicloran inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; dimethomorph inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; diniconazole inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; Disulfiram inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; dithiopyr inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; Diuron inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; Endosulfan inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; enilconazole inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; Equilin inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; Estrone inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; ethafluralin inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; Ethinyl Estradiol inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; fenamiphos inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; fenarimol inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; Fenitrothion inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; Fenthion inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; Finasteride inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; fludioxonil inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; flumetralin inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; fluoranthene inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; Flutamide inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; Genistein inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; Hexestrol inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; hydroxyflutamide inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; iprodione inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; Levonorgestrel binds to and results in increased activity of AR protein; Linuron inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; Melengestrol Acetate inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; Mestranol inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; metconazole inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; Methoxychlor inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; Methyl Parathion inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; metolachlor inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; Mitotane inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; N-(2-ethylhexyl)-5-norbornene-2,3-dicarboxamide inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; nilutamide inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; nitrofen inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; nonylphenol inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; Norgestrel binds to and results in increased activity of AR protein; o,p'-DDT inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; oryzalin inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; oxybenzone inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; p-tert-amylphenol inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; pendimethalin inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; phenanthrene inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; phenothiazine inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; phosalone inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; phoxim inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; prochloraz inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; procymidone inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; pronamide inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; Propanil inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; propiconazole inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; propylparaben inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; pyrene inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; S-methyl benzo(1,2,3)thiadiazole-7-carbothioate inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; Spironolactone inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; tebuconazole inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; Testosterone Propionate inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; tetrabromobisphenol A inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; tetrachlorodian inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; Tetrachlorvinphos inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; tri-(2-ethylhexyl)trimellitate inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; tributyltin inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; Triclosan inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; triflumizol inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; Trifluralin inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; Triiodothyronine inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; triphenyl phosphate inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; triphenyltin chloride inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; tris(1,3-dichloro-2-propyl)phosphate inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; triticonazole inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; Troglitazone inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; vinclozolin inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]
CTD PMID:14565775 PMID:19833195 PMID:20438827 PMID:33049310 NCBI chr  X:63,104,771...63,273,934
Ensembl chr  X:63,104,771...63,273,925
JBrowse link
G Arhgap23 Rho GTPase activating protein 23 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of ARHGAP23 mRNA CTD PMID:19074003 NCBI chr10:82,437,578...82,496,846
Ensembl chr10:82,394,648...82,496,504
JBrowse link
G Arl9 ADP-ribosylation factor like GTPase 9 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of ARL9 mRNA CTD PMID:19074003 NCBI chr14:31,157,585...31,166,803
Ensembl chr14:31,157,586...31,166,699
JBrowse link
G Asap1 ArfGAP with SH3 domain, ankyrin repeat and PH domain 1 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of ASAP1 mRNA CTD PMID:19074003 NCBI chr 7:95,786,130...96,093,111
Ensembl chr 7:95,787,818...96,092,754
JBrowse link
G Azgp1 alpha-2-glycoprotein 1, zinc-binding multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of AZGP1 mRNA CTD PMID:19074003 NCBI chr12:16,930,990...16,939,333
Ensembl chr12:16,931,024...16,939,091
JBrowse link
G B4galt5 beta-1,4-galactosyltransferase 5 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of B4GALT5 mRNA CTD PMID:19074003 NCBI chr 3:156,018,056...156,033,983
Ensembl chr 3:156,018,053...156,070,074
JBrowse link
G Bbx BBX high mobility group box domain containing multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of BBX mRNA CTD PMID:19074003 NCBI chr11:50,381,249...50,628,934
Ensembl chr11:50,381,247...50,623,251
JBrowse link
G Bcl2 BCL2, apoptosis regulator decreases expression ISO Levonorgestrel results in decreased expression of BCL2 protein CTD PMID:16019350 NCBI chr13:22,689,783...22,853,920 JBrowse link
G Bcl2l14 BCL2 like 14 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of BCL2L14 mRNA CTD PMID:19074003 NCBI chr 4:167,217,561...167,258,723
Ensembl chr 4:167,219,871...167,258,086
JBrowse link
G Bglap bone gamma-carboxyglutamate protein multiple interactions ISO VDR gene polymorphism affects the reaction [[Ethinyl Estradiol co-treated with Levonorgestrel] affects the expression of BGLAP protein] CTD PMID:12521655 NCBI chr 2:173,838,518...173,839,495
Ensembl chr 2:173,838,518...173,839,495
JBrowse link
G Btbd3 BTB domain containing 3 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of BTBD3 mRNA CTD PMID:19074003 NCBI chr 3:125,591,427...125,621,660
Ensembl chr 3:125,591,490...125,619,038
JBrowse link
G C3 complement C3 multiple interactions EXP Levonorgestrel inhibits the reaction [Ethinyl Estradiol results in increased expression of C3 mRNA] CTD PMID:11566438 NCBI chr 9:2,087,437...2,114,366
Ensembl chr 9:2,087,437...2,114,429
JBrowse link
G C4bpb complement component 4 binding protein, beta multiple interactions ISO [Ethinyl Estradiol co-treated with Levonorgestrel] results in decreased expression of C4BPB protein; F5 gene polymorphism inhibits the reaction [[Ethinyl Estradiol co-treated with Levonorgestrel] results in decreased expression of C4BPB protein] CTD PMID:14551147 NCBI chr13:42,120,798...42,131,515
Ensembl chr13:42,120,798...42,131,817
JBrowse link
G Cat catalase multiple interactions ISO [Ethinyl Estradiol co-treated with Levonorgestrel] results in decreased activity of CAT protein CTD PMID:17541152 NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
JBrowse link
G Ccn3 cellular communication network factor 3 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of CCN3 mRNA CTD PMID:19074003 NCBI chr 7:86,094,000...86,101,022
Ensembl chr 7:86,094,000...86,101,019
JBrowse link
G Cd86 CD86 molecule multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of CD86 mRNA CTD PMID:19074003 NCBI chr11:64,142,193...64,200,816
Ensembl chr11:64,163,828...64,200,818
JBrowse link
G Cdc25c cell division cycle 25C multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of CDC25C mRNA CTD PMID:19074003 NCBI chr18:26,335,156...26,356,199
Ensembl chr18:26,335,834...26,356,185
JBrowse link
G Cdc42bpb CDC42 binding protein kinase beta multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of CDC42BPB mRNA CTD PMID:19074003 NCBI chr 6:130,333,712...130,416,631
Ensembl chr 6:130,333,712...130,416,377
JBrowse link
G Cdkn2d cyclin dependent kinase inhibitor 2D multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of CDKN2D mRNA CTD PMID:19074003 NCBI chr 8:19,831,874...19,834,640
Ensembl chr 8:19,831,866...19,834,674
JBrowse link
G Cep170b centrosomal protein 170B multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of CEP170B mRNA CTD PMID:19074003 NCBI chr 6:131,780,935...131,806,658
Ensembl chr 6:131,778,957...131,806,658
JBrowse link
G Cfap65 cilia and flagella associated protein 65 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of CFAP65 mRNA CTD PMID:19074003 NCBI chr 9:76,459,211...76,494,199
Ensembl chr 9:76,459,211...76,494,128
JBrowse link
G Chek2 checkpoint kinase 2 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of CHEK2 mRNA CTD PMID:19074003 NCBI chr12:45,788,823...45,821,382
Ensembl chr12:45,788,827...45,821,286
JBrowse link
G Col1a1 collagen type I alpha 1 chain multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of COL1A1 mRNA CTD PMID:19074003 NCBI chr10:79,883,622...79,900,625
Ensembl chr10:79,883,622...79,900,624
JBrowse link
G Col22a1 collagen type XXII alpha 1 chain multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of COL22A1 mRNA CTD PMID:19074003 NCBI chr 7:103,730,939...103,968,452
Ensembl chr 7:103,731,037...103,968,462
JBrowse link
G Cpeb3 cytoplasmic polyadenylation element binding protein 3 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of CPEB3 mRNA CTD PMID:19074003 NCBI chr 1:234,749,138...234,931,219
Ensembl chr 1:234,751,733...234,931,560
JBrowse link
G Cpxcr1 CPX chromosome region, candidate 1 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of CPXCR1 mRNA CTD PMID:19074003 NCBI chr  X:81,756,909...81,794,661 JBrowse link
G Crlf3 cytokine receptor-like factor 3 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of CRLF3 mRNA CTD PMID:19074003 NCBI chr10:65,024,228...65,060,746
Ensembl chr10:65,023,388...65,060,670
JBrowse link
G Crp C-reactive protein multiple interactions ISO [Ethinyl Estradiol co-treated with Levonorgestrel] results in increased expression of CRP protein CTD PMID:15769986 NCBI chr13:85,131,635...85,175,179
Ensembl chr13:85,124,977...85,175,178
JBrowse link
G Csmd1 CUB and Sushi multiple domains 1 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of CSMD1 mRNA CTD PMID:19074003 NCBI chr16:72,218,189...73,818,380
Ensembl chr16:72,218,503...73,817,614
JBrowse link
G Csnk1a1 casein kinase 1, alpha 1 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of CSNK1A1 mRNA CTD PMID:19074003 NCBI chr18:55,017,049...55,050,184
Ensembl chr18:55,017,055...55,049,271
JBrowse link
G Cxcl10 C-X-C motif chemokine ligand 10 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of CXCL10 mRNA CTD PMID:19074003 NCBI chr14:15,704,772...15,706,969
Ensembl chr14:15,704,758...15,706,975
JBrowse link
G Cyp17a1 cytochrome P450, family 17, subfamily a, polypeptide 1 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of CYP17A1 mRNA CTD PMID:19074003 NCBI chr 1:245,535,462...245,543,148
Ensembl chr 1:245,535,462...245,541,573
JBrowse link
G Dap3 death associated protein 3 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of DAP3 mRNA CTD PMID:19074003 NCBI chr 2:174,319,341...174,347,489
Ensembl chr 2:174,318,983...174,346,461
JBrowse link
G Dcn decorin multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of DCN mRNA CTD PMID:19074003 NCBI chr 7:32,281,252...32,321,291
Ensembl chr 7:32,281,252...32,321,270
JBrowse link
G Ddhd1 DDHD domain containing 1 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of DDHD1 mRNA CTD PMID:19074003 NCBI chr15:18,824,389...18,891,036
Ensembl chr15:18,824,394...18,890,952
JBrowse link
G Dlgap2 DLG associated protein 2 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of DLGAP2 mRNA CTD PMID:19074003 NCBI chr16:74,786,771...75,496,402
Ensembl chr16:74,791,509...75,496,407
JBrowse link
G Dnase1l3 deoxyribonuclease 1-like 3 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of DNASE1L3 mRNA CTD PMID:19074003 NCBI chr15:16,922,335...16,948,322
Ensembl chr15:16,922,335...16,948,317
JBrowse link
G Dock8 dedicator of cytokinesis 8 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of DOCK8 mRNA CTD PMID:19074003 NCBI chr 1:222,649,309...222,842,474
Ensembl chr 1:222,649,309...222,842,474
JBrowse link
G Dok5 docking protein 5 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of DOK5 mRNA CTD PMID:19074003 NCBI chr 3:159,515,886...159,652,811
Ensembl chr 3:159,515,893...159,652,810
JBrowse link
G Dsg1 desmoglein 1 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of DSG1 mRNA CTD PMID:19074003 NCBI chr18:11,674,687...11,705,383
Ensembl chr18:11,674,402...11,703,443
JBrowse link
G Elovl5 ELOVL fatty acid elongase 5 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of ELOVL5 mRNA CTD PMID:19074003 NCBI chr 8:78,790,799...78,857,307
Ensembl chr 8:78,790,846...78,857,284
JBrowse link
G Eprs glutamyl-prolyl-tRNA synthetase multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of EPRS1 mRNA CTD PMID:19074003 NCBI chr13:96,901,548...96,971,966
Ensembl chr13:96,901,575...96,971,966
JBrowse link
G Esr1 estrogen receptor 1 increases activity
multiple interactions
EXP
ISO
Norgestrel results in increased activity of ESR1 protein
Levonorgestrel binds to and results in increased activity of ESR1 protein; Norgestrel binds to and results in increased activity of ESR1 protein
CTD PMID:11750080 PMID:12504345 PMID:33049310 NCBI chr 1:41,106,335...41,499,104
Ensembl chr 1:41,210,475...41,495,002
JBrowse link
G Etnk1 ethanolamine kinase 1 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of ETNK1 mRNA CTD PMID:19074003 NCBI chr 4:176,126,056...176,170,325
Ensembl chr 4:176,126,180...176,193,770
JBrowse link
G Evi2b ecotropic viral integration site 2B multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of EVI2B mRNA CTD PMID:19074003 NCBI chr10:64,472,693...64,474,311
Ensembl chr10:64,471,505...64,481,560
JBrowse link
G F5 coagulation factor V multiple interactions ISO F5 gene polymorphism inhibits the reaction [[Ethinyl Estradiol co-treated with Levonorgestrel] results in decreased expression of C4BPB protein] CTD PMID:14551147 NCBI chr13:76,513,463...76,583,106
Ensembl chr13:76,513,255...76,582,317
JBrowse link
G F7 coagulation factor VII multiple interactions ISO [Ethinyl Estradiol co-treated with Levonorgestrel] results in decreased expression of F7 protein; [Ethinyl Estradiol co-treated with Levonorgestrel] results in increased expression of F7 protein CTD PMID:12618251 PMID:15157790 NCBI chr16:76,489,779...76,500,636
Ensembl chr16:76,489,717...76,500,610
JBrowse link
G F8 coagulation factor VIII multiple interactions ISO [Ethinyl Estradiol co-treated with Levonorgestrel] results in increased expression of F8 protein CTD PMID:12618251 NCBI chr18:140,848...172,330
Ensembl chr18:140,955...171,857
JBrowse link
G Fabp4 fatty acid binding protein 4 multiple interactions ISO [Norgestrel co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of FABP4 protein; Norgestrel inhibits the reaction [[Dexamethasone co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of FABP4 protein] CTD PMID:29782964 NCBI chr 2:91,580,858...91,585,578
Ensembl chr 2:91,580,885...91,585,578
JBrowse link
G Fam20a FAM20A, golgi associated secretory pathway pseudokinase multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of FAM20A mRNA CTD PMID:19074003 NCBI chr10:94,638,836...94,697,814
Ensembl chr10:94,642,850...94,697,672
JBrowse link
G Far2 fatty acyl CoA reductase 2 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of FAR2 mRNA CTD PMID:19074003 NCBI chr 4:180,973,968...181,087,862
Ensembl chr 4:181,007,622...181,087,255
JBrowse link
G Fcrl5 Fc receptor-like 5 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of FCRL5 mRNA CTD PMID:19074003 NCBI chr 2:172,881,763...172,912,912
Ensembl chr 2:172,881,448...172,913,148
JBrowse link
G Fermt2 FERM domain containing kindlin 2 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of FERMT2 mRNA CTD PMID:19074003 NCBI chr15:18,682,927...18,751,959
Ensembl chr15:18,682,927...18,751,811
JBrowse link
G Fga fibrinogen alpha chain multiple interactions ISO [Ethinyl Estradiol co-treated with Levonorgestrel] results in increased expression of [FGA protein binds to FGB protein binds to FGG protein] CTD PMID:12618251 PMID:15288212 NCBI chr 2:168,365,364...168,381,533
Ensembl chr 2:168,374,120...168,381,528
JBrowse link
G Fgb fibrinogen beta chain multiple interactions ISO [Ethinyl Estradiol co-treated with Levonorgestrel] results in increased expression of [FGA protein binds to FGB protein binds to FGG protein] CTD PMID:12618251 PMID:15288212 NCBI chr 2:168,394,901...168,402,863
Ensembl chr 2:168,394,916...168,405,979
JBrowse link
G Fgg fibrinogen gamma chain multiple interactions ISO [Ethinyl Estradiol co-treated with Levonorgestrel] results in increased expression of [FGA protein binds to FGB protein binds to FGG protein] CTD PMID:12618251 PMID:15288212 NCBI chr 2:168,354,880...168,362,325
Ensembl chr 2:168,355,013...168,362,322
JBrowse link
G Fkbp6 FKBP prolyl isomerase family member 6 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of FKBP6 mRNA CTD PMID:19074003 NCBI chr12:21,318,251...21,390,350
Ensembl chr12:21,319,568...21,390,350
JBrowse link
G Fmnl3 formin-like 3 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of FMNL3 mRNA CTD PMID:19074003 NCBI chr 7:130,454,270...130,505,621
Ensembl chr 7:130,454,275...130,505,626
JBrowse link
G Fnbp1 formin binding protein 1 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of FNBP1 mRNA CTD PMID:19074003 NCBI chr 3:14,316,011...14,386,704
Ensembl chr 3:14,309,640...14,424,881
JBrowse link
G Fshb follicle stimulating hormone subunit beta multiple interactions ISO [Ethinyl Estradiol co-treated with Levonorgestrel] results in decreased expression of FSHB protein; Avosentan affects the reaction [[Ethinyl Estradiol co-treated with Levonorgestrel] affects the expression of FSHB protein] CTD PMID:16291413 PMID:17190377 NCBI chr 3:93,548,560...93,552,370
Ensembl chr 3:93,548,560...93,552,370
JBrowse link
G Gabrg2 gamma-aminobutyric acid type A receptor subunit gamma 2 increases expression EXP Levonorgestrel results in increased expression of GABRG2 protein CTD PMID:22634062 NCBI chr10:26,376,805...26,463,680
Ensembl chr10:26,374,694...26,464,346
JBrowse link
G Gas6 growth arrest specific 6 multiple interactions ISO [Ethinyl Estradiol co-treated with Levonorgestrel] results in decreased expression of GAS6 protein CTD PMID:17717130 NCBI chr16:76,045,430...76,075,904
Ensembl chr16:76,045,426...76,075,904
JBrowse link
G Gdf10 growth differentiation factor 10 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of GDF10 mRNA CTD PMID:19074003 NCBI chr16:9,237,182...9,250,537
Ensembl chr16:9,237,261...9,249,343
JBrowse link
G Gh1 growth hormone 1 multiple interactions ISO [Ethinyl Estradiol co-treated with Levonorgestrel] results in increased expression of GH1 protein CTD PMID:11172797 NCBI chr10:91,228,102...91,230,079
Ensembl chr10:91,228,103...91,230,078
JBrowse link
G Glyr1 glyoxylate reductase 1 homolog multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of GLYR1 mRNA CTD PMID:19074003 NCBI chr10:10,532,036...10,567,639
Ensembl chr10:10,532,154...10,567,637
JBrowse link
G Gpr135 G protein-coupled receptor 135 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of GPR135 mRNA CTD PMID:19074003 NCBI chr 6:90,627,533...90,636,311
Ensembl chr 6:90,629,178...90,630,551
JBrowse link
G Greb1 growth regulating estrogen receptor binding 1 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of GREB1 mRNA CTD PMID:19074003 NCBI chr 6:39,440,522...39,562,364
Ensembl chr 6:39,440,504...39,581,633
JBrowse link
G Hmmr hyaluronan-mediated motility receptor multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of HMMR mRNA CTD PMID:19074003 NCBI chr10:25,132,933...25,163,029
Ensembl chr10:25,132,977...25,163,060
JBrowse link
G Hoxc6 homeo box C6 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of HOXC6 mRNA CTD PMID:19074003 NCBI chr 7:134,138,017...134,148,899 JBrowse link
G Htr7 5-hydroxytryptamine receptor 7 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of HTR7 mRNA CTD PMID:19074003 NCBI chr 1:233,636,442...233,761,063
Ensembl chr 1:233,636,452...233,760,626
JBrowse link
G Ice2 interactor of little elongation complex ELL subunit 2 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of ICE2 mRNA CTD PMID:19074003 NCBI chr 8:70,043,419...70,085,217
Ensembl chr 8:70,043,424...70,084,995
JBrowse link
G Igf1 insulin-like growth factor 1 multiple interactions ISO [Ethinyl Estradiol co-treated with Levonorgestrel] results in decreased expression of IGF1 protein CTD PMID:11172797 NCBI chr 7:22,282,895...22,361,972
Ensembl chr 7:22,282,930...22,359,296
JBrowse link
G Igfbp3 insulin-like growth factor binding protein 3 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of IGFBP3 mRNA CTD PMID:19074003 NCBI chr14:82,056,347...82,064,083
Ensembl chr14:82,056,347...82,064,083
JBrowse link
G Igsf1 immunoglobulin superfamily, member 1 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of IGSF1 mRNA CTD PMID:19074003 NCBI chr  X:129,069,891...129,085,331
Ensembl chr  X:129,069,896...129,085,139
JBrowse link
G Inha inhibin subunit alpha multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of INHA mRNA CTD PMID:19074003 NCBI chr 9:76,994,465...76,997,366
Ensembl chr 9:76,993,589...76,997,248
JBrowse link
G Ins2 insulin 2 multiple interactions ISO [Norgestrel co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of FABP4 protein; Norgestrel inhibits the reaction [[Dexamethasone co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of and results in increased secretion of ADIPOQ protein]; Norgestrel inhibits the reaction [[Dexamethasone co-treated with Rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of FABP4 protein] CTD PMID:29782964 NCBI chr 1:197,843,277...197,992,522
Ensembl chr 1:197,843,281...197,864,775
JBrowse link
G Insl3 insulin-like 3 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of INSL3 mRNA CTD PMID:19074003 NCBI chr16:18,398,682...18,400,566
Ensembl chr16:18,384,829...18,400,560
JBrowse link
G Insl6 insulin-like 6 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of INSL6 mRNA CTD PMID:19074003 NCBI chr 1:227,069,958...227,073,493
Ensembl chr 1:227,069,958...227,073,493
JBrowse link
G Kbtbd7 kelch repeat and BTB domain containing 7 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of KBTBD7 mRNA CTD PMID:19074003 NCBI chr15:54,806,878...54,811,457
Ensembl chr15:54,806,873...54,811,687
JBrowse link
G Kcnh7 potassium voltage-gated channel subfamily H member 7 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of KCNH7 mRNA CTD PMID:19074003 NCBI chr 3:47,329,338...47,822,122
Ensembl chr 3:47,338,501...47,822,195
JBrowse link
G Kdsr 3-ketodihydrosphingosine reductase multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of KDSR mRNA CTD PMID:19074003 NCBI chr13:22,862,117...22,894,118
Ensembl chr13:22,862,117...22,894,108
JBrowse link
G Klhl28 kelch-like family member 28 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of KLHL28 mRNA CTD PMID:19074003 NCBI chr 6:82,987,360...83,018,971
Ensembl chr 6:82,990,945...83,016,164
JBrowse link
G Klhl4 kelch-like family member 4 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of KLHL4 mRNA CTD PMID:19074003 NCBI chr  X:79,429,193...79,719,482
Ensembl chr  X:79,622,113...79,719,480
JBrowse link
G Ldlr low density lipoprotein receptor affects expression
multiple interactions
ISO Levonorgestrel affects the expression of LDLR protein
[Levonorgestrel co-treated with Ethinyl Estradiol] results in decreased expression of LDLR protein
CTD PMID:17900441 NCBI chr 8:20,270,020...20,292,981
Ensembl chr 8:20,270,041...20,294,580
JBrowse link
G Lhb luteinizing hormone subunit beta multiple interactions
decreases secretion
ISO [Ethinyl Estradiol co-treated with Levonorgestrel] results in decreased expression of LHB protein; Avosentan affects the reaction [[Ethinyl Estradiol co-treated with Levonorgestrel] affects the expression of LHB protein]
Levonorgestrel results in decreased secretion of LHB protein
CTD PMID:16291413 PMID:17190377 PMID:20599585 NCBI chr 1:95,898,269...95,901,973
Ensembl chr 1:95,900,984...95,901,972
Ensembl chr 1:95,900,984...95,901,972
JBrowse link
G Limd1 LIM domain containing 1 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of LIMD1 mRNA CTD PMID:19074003 NCBI chr 8:123,121,363...123,168,476
Ensembl chr 8:123,122,460...123,167,714
JBrowse link
G Lmntd1 lamin tail domain containing 1 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of LMNTD1 mRNA CTD PMID:19074003 NCBI chr 4:178,354,305...178,588,483
Ensembl chr 4:178,354,137...178,588,477
JBrowse link
G LOC681470 similar to olfactory receptor 1403 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of OR10J1 mRNA CTD PMID:19074003 NCBI chr13:85,723,330...85,724,262
Ensembl chr13:85,719,234...85,724,767
JBrowse link
G Lrig2 leucine-rich repeats and immunoglobulin-like domains 2 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of LRIG2 mRNA CTD PMID:19074003 NCBI chr 2:191,947,322...192,012,996
Ensembl chr 2:191,949,819...192,012,579
JBrowse link
G Man2a1 mannosidase, alpha, class 2A, member 1 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of MAN2A1 mRNA CTD PMID:19074003 NCBI chr 9:104,252,001...104,408,349
Ensembl chr 9:104,252,001...104,408,349
JBrowse link
G Mbnl1 muscleblind-like splicing regulator 1 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of MBNL1 mRNA CTD PMID:19074003 NCBI chr 2:144,639,819...144,814,395
Ensembl chr 2:144,670,285...144,814,368
JBrowse link
G Mep1b meprin A subunit beta multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of MEP1B mRNA CTD PMID:19074003 NCBI chr18:12,366,126...12,392,840
Ensembl chr18:12,365,289...12,392,840
JBrowse link
G Midn midnolin multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of MIDN mRNA CTD PMID:19074003 NCBI chr 7:9,548,100...9,559,605
Ensembl chr 7:9,549,650...9,559,752
JBrowse link
G Mki67 marker of proliferation Ki-67 decreases expression ISO Levonorgestrel results in decreased expression of MKI67 protein CTD PMID:16019350 NCBI chr 1:190,496,319...190,522,983
Ensembl chr 1:190,496,319...190,522,762
JBrowse link
G Mro maestro multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of MRO mRNA CTD PMID:19074003 NCBI chr18:67,450,186...67,467,593 JBrowse link
G Mrps6 mitochondrial ribosomal protein S6 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of MRPS6 mRNA CTD PMID:19074003 NCBI chr11:31,295,358...31,348,483
Ensembl chr11:31,295,614...31,348,484
JBrowse link
G Mtss1 MTSS I-BAR domain containing 1 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of MTSS1 mRNA CTD PMID:19074003 NCBI chr 7:90,488,751...90,628,007
Ensembl chr 7:90,488,754...90,627,968
JBrowse link
G Mysm1 myb-like, SWIRM and MPN domains 1 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of MYSM1 mRNA CTD PMID:19074003 NCBI chr 5:109,761,345...109,826,652
Ensembl chr 5:109,776,286...109,819,967
JBrowse link
G Nacc2 NACC family member 2 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of NACC2 mRNA CTD PMID:19074003 NCBI chr 3:8,879,952...8,946,660
Ensembl chr 3:8,883,065...8,946,660
JBrowse link
G Ndfip1 Nedd4 family interacting protein 1 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of NDFIP1 mRNA CTD PMID:19074003 NCBI chr18:30,265,808...30,316,068
Ensembl chr18:30,250,613...30,322,311
JBrowse link
G Nexn nexilin (F actin binding protein) multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of NEXN mRNA CTD PMID:19074003 NCBI chr 2:241,186,783...241,218,315
Ensembl chr 2:241,186,790...241,218,342
JBrowse link
G Nid1 nidogen 1 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of NID1 mRNA CTD PMID:19074003 NCBI chr17:86,085,046...86,158,277
Ensembl chr17:86,085,077...86,158,267
JBrowse link
G Nr1i2 nuclear receptor subfamily 1, group I, member 2 multiple interactions ISO Levonorgestrel binds to and results in increased activity of NR1I2 protein
Levonorgestrel binds to and results in increased activity of NR1I2 protein; Norgestrel binds to and results in increased activity of NR1I2 protein
CTD PMID:33049310 NCBI chr11:62,460,213...62,496,665
Ensembl chr11:62,460,213...62,496,658
JBrowse link
G Nsg1 neuronal vesicle trafficking associated 1 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of NSG1 mRNA CTD PMID:19074003 NCBI chr14:72,648,771...72,670,521
Ensembl chr14:72,648,741...72,670,514
JBrowse link
G Odf3 outer dense fiber of sperm tails 3 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of ODF3 mRNA CTD PMID:19074003 NCBI chr 1:195,926,034...195,929,250
Ensembl chr 1:195,926,041...195,929,248
JBrowse link
G Olfml3 olfactomedin-like 3 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of OLFML3 mRNA CTD PMID:19074003 NCBI chr 2:191,244,221...191,247,050
Ensembl chr 2:191,244,221...191,247,050
JBrowse link
G Opn5 opsin 5 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of OPN5 mRNA CTD PMID:19074003 NCBI chr 9:18,368,393...18,416,098
Ensembl chr 9:18,368,416...18,415,476
JBrowse link
G Osbpl10 oxysterol binding protein-like 10 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of OSBPL10 mRNA CTD PMID:19074003 NCBI chr 8:114,661,050...114,918,664
Ensembl chr 8:114,660,743...114,918,625
JBrowse link
G Pak3 p21 (RAC1) activated kinase 3 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of PAK3 mRNA CTD PMID:19074003 NCBI chr  X:107,116,308...107,374,342
Ensembl chr  X:107,260,898...107,368,314
JBrowse link
G Pappa1 pappalysin 1 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of PAPPA mRNA CTD PMID:19074003 NCBI chr 5:78,497,660...78,735,873
Ensembl chr 5:78,498,300...78,730,666
JBrowse link
G Pard6b par-6 family cell polarity regulator beta multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of PARD6B mRNA CTD PMID:19074003 NCBI chr 3:156,790,540...156,811,620
Ensembl chr 3:156,790,540...156,811,622
JBrowse link
G Pcdh7 protocadherin 7 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of PCDH7 mRNA CTD PMID:19074003 NCBI chr14:52,471,801...52,901,696
Ensembl chr14:52,475,610...52,902,051
Ensembl chr14:52,475,610...52,902,051
JBrowse link
G Pde1c phosphodiesterase 1C multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of PDE1C mRNA CTD PMID:19074003 NCBI chr 4:85,300,858...85,777,948
Ensembl chr 4:85,300,858...85,863,219
JBrowse link
G Pgr progesterone receptor multiple interactions ISO Levonorgestrel binds to and results in increased activity of PGR protein CTD PMID:20599585 NCBI chr 8:6,073,216...6,131,552
Ensembl chr 8:6,072,673...6,131,344
JBrowse link
G Pkp4 plakophilin 4 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of PKP4 mRNA CTD PMID:19074003 NCBI chr 3:43,632,364...43,835,834
Ensembl chr 3:43,631,880...43,835,474
JBrowse link
G Plagl1 PLAG1 like zinc finger 1 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of PLAGL1 mRNA CTD PMID:19074003 NCBI chr 1:7,477,295...7,517,229
Ensembl chr 1:7,477,177...7,517,228
JBrowse link
G Plat plasminogen activator, tissue type multiple interactions ISO [Ethinyl Estradiol co-treated with Levonorgestrel] results in decreased expression of PLAT protein; [Ethinyl Estradiol co-treated with Levonorgestrel] results in increased activity of PLAT protein CTD PMID:12618251 PMID:15157790 PMID:15288212 NCBI chr16:69,240,582...69,265,177
Ensembl chr16:69,240,585...69,268,223
JBrowse link
G Plg plasminogen multiple interactions ISO [Ethinyl Estradiol co-treated with Levonorgestrel] results in increased expression of PLG protein CTD PMID:12618251 PMID:15157790 NCBI chr 1:48,325,186...48,367,643
Ensembl chr 1:48,325,185...48,367,786
JBrowse link
G Poglut1 protein O-glucosyltransferase 1 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of POGLUT1 mRNA CTD PMID:19074003 NCBI chr11:62,198,600...62,226,446
Ensembl chr11:62,198,513...62,226,434
JBrowse link
G Pon1 paraoxonase 1 multiple interactions ISO [Ethinyl Estradiol co-treated with Levonorgestrel] affects the activity of PON1 protein CTD PMID:17541152 NCBI chr 4:33,294,737...33,325,759
Ensembl chr 4:33,294,722...33,321,360
JBrowse link
G Ppp2r2c protein phosphatase 2, regulatory subunit B, gamma multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of PPP2R2C mRNA CTD PMID:19074003 NCBI chr14:73,846,547...73,931,178
Ensembl chr14:73,846,547...73,931,864
JBrowse link
G Prkab1 protein kinase AMP-activated non-catalytic subunit beta 1 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of PRKAB1 mRNA CTD PMID:19074003 NCBI chr12:40,588,140...40,598,673
Ensembl chr12:40,588,211...40,598,661
JBrowse link
G Proc protein C, inactivator of coagulation factors Va and VIIIa multiple interactions ISO [Ethinyl Estradiol co-treated with Levonorgestrel] results in increased activity of PROC protein; [Ethinyl Estradiol co-treated with Levonorgestrel] results in increased expression of PROC protein CTD PMID:12618251 PMID:14551147 PMID:15288212 NCBI chr18:23,764,367...23,774,816
Ensembl chr18:23,764,368...23,775,133
JBrowse link
G Pros1 protein S multiple interactions ISO [Ethinyl Estradiol co-treated with Levonorgestrel] results in decreased activity of PROS1 protein; [Ethinyl Estradiol co-treated with Levonorgestrel] results in decreased expression of PROS1 protein CTD PMID:12618251 PMID:14551147 NCBI chr11:230,597...311,288
Ensembl chr11:230,696...311,286
JBrowse link
G Ptbp2 polypyrimidine tract binding protein 2 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of PTBP2 mRNA CTD PMID:19074003 NCBI chr 2:207,812,659...207,874,019
Ensembl chr 2:207,812,920...207,873,506
JBrowse link
G Ptger2 prostaglandin E receptor 2 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of PTGER2 mRNA CTD PMID:19074003 NCBI chr15:18,215,013...18,228,714
Ensembl chr15:18,217,285...18,228,714
JBrowse link
G Ptges prostaglandin E synthase multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of PTGES mRNA CTD PMID:19074003 NCBI chr 3:14,177,892...14,189,236 JBrowse link
G Rab11fip3 RAB11 family interacting protein 3 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of RAB11FIP3 mRNA CTD PMID:19074003 NCBI chr10:15,002,650...15,086,382
Ensembl chr10:15,002,926...15,118,479
JBrowse link
G Rab1a RAB1A, member RAS oncogene family multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of RAB1A mRNA CTD PMID:19074003 NCBI chr14:94,422,219...94,448,799
Ensembl chr14:94,415,275...94,448,248
JBrowse link
G Rapgef6 Rap guanine nucleotide exchange factor 6 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of RAPGEF6 mRNA CTD PMID:19074003 NCBI chr10:38,655,854...38,824,227
Ensembl chr10:38,655,867...38,823,211
JBrowse link
G Recql RecQ like helicase multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of RECQL mRNA CTD PMID:19074003 NCBI chr 4:175,308,337...175,332,965
Ensembl chr 4:175,304,117...175,332,945
JBrowse link
G Rftn2 raftlin family member 2 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of RFTN2 mRNA CTD PMID:19074003 NCBI chr 9:56,651,617...56,707,830
Ensembl chr 9:56,630,460...56,707,810
JBrowse link
G Rln1 relaxin 1 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of RLN1 mRNA CTD PMID:19074003 NCBI chr 1:227,079,960...227,082,960
Ensembl chr 1:227,079,966...227,082,882
JBrowse link
G Rnf216 ring finger protein 216 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of RNF216 mRNA CTD PMID:19074003 NCBI chr12:11,454,752...11,576,305
Ensembl chr12:11,454,797...11,576,304
JBrowse link
G Rnft1 ring finger protein, transmembrane 1 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of RNFT1 mRNA CTD PMID:19074003 NCBI chr10:71,310,052...71,322,507
Ensembl chr10:71,310,104...71,323,778
JBrowse link
G RT1-Bb RT1 class II, locus Bb multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of HLA-DQB1 mRNA CTD PMID:19074003 NCBI chr20:4,596,558...4,602,201
Ensembl chr20:4,596,559...4,607,597
JBrowse link
G Saraf store-operated calcium entry-associated regulatory factor multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of SARAF mRNA CTD PMID:19074003 NCBI chr16:58,017,231...58,035,481
Ensembl chr16:58,017,231...58,035,545
JBrowse link
G Scaf4 SR-related CTD-associated factor 4 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of SCAF4 mRNA CTD PMID:19074003 NCBI chr11:29,460,479...29,521,153
Ensembl chr11:29,465,106...29,521,153
JBrowse link
G Senp1 SUMO specific peptidase 1 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of SENP1 mRNA CTD PMID:19074003 NCBI chr 7:129,163,173...129,226,766
Ensembl chr 7:129,165,774...129,221,598
JBrowse link
G Serpina5 serpin family A member 5 multiple interactions ISO [Ethinyl Estradiol co-treated with Levonorgestrel] results in increased expression of SERPINA5 protein CTD PMID:14551147 NCBI chr 6:123,009,224...123,028,412
Ensembl chr 6:123,023,306...123,028,407
JBrowse link
G Serpinb3 serpin family B member 3 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of SERPINB3 mRNA CTD PMID:19074003 NCBI chr13:23,274,120...23,280,082
Ensembl chr13:23,274,484...23,313,682
JBrowse link
G Serpinc1 serpin family C member 1 multiple interactions ISO [Ethinyl Estradiol co-treated with Levonorgestrel] results in decreased activity of SERPINC1 protein; [Ethinyl Estradiol co-treated with Levonorgestrel] results in decreased expression of SERPINC1 protein CTD PMID:12618251 PMID:14981370 PMID:15288212 NCBI chr13:73,257,208...73,271,476
Ensembl chr13:73,257,179...73,284,293
JBrowse link
G Serpine1 serpin family E member 1 multiple interactions ISO [Ethinyl Estradiol co-treated with Levonorgestrel] results in decreased activity of SERPINE1 protein; [Ethinyl Estradiol co-treated with Levonorgestrel] results in decreased expression of SERPINE1 protein CTD PMID:14981370 PMID:15157790 PMID:15288212 NCBI chr12:19,601,272...19,611,657
Ensembl chr12:19,601,272...19,611,657
JBrowse link
G Sfrp5 secreted frizzled-related protein 5 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of SFRP5 mRNA CTD PMID:19074003 NCBI chr 1:241,006,762...241,011,224
Ensembl chr 1:241,006,762...241,011,224
JBrowse link
G Shbg sex hormone binding globulin affects binding
multiple interactions
ISO Levonorgestrel binds to SHBG protein
[Ethinyl Estradiol co-treated with Levonorgestrel] results in increased expression of SHBG protein
CTD PMID:12586319 PMID:14981370 PMID:17519148 NCBI chr10:54,332,939...54,350,409
Ensembl chr10:54,332,941...54,351,057
JBrowse link
G Slc16a9 solute carrier family 16, member 9 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of SLC16A9 mRNA CTD PMID:19074003 NCBI chr20:18,336,142...18,377,154 JBrowse link
G Slc25a2 solute carrier family 25 member 2 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of SLC25A2 mRNA CTD PMID:19074003 NCBI chr18:29,452,943...29,457,906
Ensembl chr18:29,453,582...29,460,383
JBrowse link
G Slc2a5 solute carrier family 2 member 5 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of SLC2A5 mRNA CTD PMID:19074003 NCBI chr 5:160,583,055...160,609,994
Ensembl chr 5:160,583,234...160,611,106
JBrowse link
G Smyd2 SET and MYND domain containing 2 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of SMYD2 mRNA CTD PMID:19074003 NCBI chr13:101,425,270...101,466,576
Ensembl chr13:101,425,273...101,466,576
JBrowse link
G Snrpn small nuclear ribonucleoprotein polypeptide N multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of SNRPN mRNA CTD PMID:19074003 NCBI chr 1:111,101,327...111,123,400 JBrowse link
G Sobp sine oculis binding protein homolog multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of SOBP mRNA CTD PMID:19074003 NCBI chr20:46,482,265...46,661,452
Ensembl chr20:46,482,765...46,663,541
JBrowse link
G Spin4 spindlin family, member 4 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of SPIN4 mRNA CTD PMID:19074003 NCBI chr  X:59,888,728...59,893,761 JBrowse link
G Sptbn1 spectrin, beta, non-erythrocytic 1 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of SPTBN1 mRNA CTD PMID:19074003 NCBI chr14:103,842,684...104,008,507
Ensembl chr14:103,842,684...104,008,507
JBrowse link
G Srgn serglycin multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of SRGN mRNA CTD PMID:19074003 NCBI chr20:30,442,810...30,479,549
Ensembl chr20:30,442,813...30,457,406
JBrowse link
G Stxbp5l syntaxin binding protein 5L multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of STXBP5L mRNA CTD PMID:19074003 NCBI chr11:63,334,667...63,654,270
Ensembl chr11:63,334,667...63,657,014
JBrowse link
G Syt11 synaptotagmin 11 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of SYT11 mRNA CTD PMID:19074003 NCBI chr 2:174,206,032...174,232,540
Ensembl chr 2:174,206,191...174,231,964
JBrowse link
G Thrb thyroid hormone receptor beta multiple interactions ISO Levonorgestrel binds to and results in increased activity of THRB protein CTD PMID:33049310 NCBI chr15:7,685,180...8,031,920
Ensembl chr15:7,685,180...7,882,916
JBrowse link
G Tmem217 transmembrane protein 217 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of TMEM217 mRNA CTD PMID:19074003 NCBI chr20:7,584,177...7,619,023
Ensembl chr20:7,592,627...7,619,111
Ensembl chr20:7,592,627...7,619,111
JBrowse link
G Tmem225 transmembrane protein 225 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of TMEM225 mRNA CTD PMID:19074003 NCBI chr 8:40,497,483...40,500,041
Ensembl chr 8:40,497,483...40,500,041
JBrowse link
G Tmem35a transmembrane protein 35A multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of TMEM35A mRNA CTD PMID:19074003 NCBI chr  X:97,503,350...97,514,198
Ensembl chr  X:97,503,350...97,514,197
JBrowse link
G Tmod2 tropomodulin 2 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of TMOD2 mRNA CTD PMID:19074003 NCBI chr 8:76,316,736...76,366,003
Ensembl chr 8:76,325,667...76,365,720
JBrowse link
G Tnf tumor necrosis factor multiple interactions ISO [Ethinyl Estradiol co-treated with Levonorgestrel] results in increased expression of TNF protein CTD PMID:15769986 NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
JBrowse link
G Tnfrsf11b TNF receptor superfamily member 11B increases expression ISO Levonorgestrel results in increased expression of TNFRSF11B mRNA CTD PMID:16114553 NCBI chr 7:85,566,520...85,594,526
Ensembl chr 7:85,566,520...85,594,538
JBrowse link
G Tnfsf11 TNF superfamily member 11 decreases expression ISO Levonorgestrel results in decreased expression of TNFSF11 mRNA CTD PMID:16114553 NCBI chr15:53,674,990...53,705,171
Ensembl chr15:53,673,877...53,705,445
JBrowse link
G Tnrc6b trinucleotide repeat containing adaptor 6B multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of TNRC6B mRNA CTD PMID:19074003 NCBI chr 7:112,252,351...112,469,829
Ensembl chr 7:112,252,359...112,461,790
JBrowse link
G Tra2a transformer 2 alpha homolog multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of TRA2A mRNA CTD PMID:19074003 NCBI chr 4:78,220,838...78,239,737
Ensembl chr 4:78,220,883...78,239,712
JBrowse link
G Trmt13 tRNA methyltransferase 13 homolog multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of TRMT13 mRNA CTD PMID:19074003 NCBI chr 2:204,533,630...204,547,711
Ensembl chr 2:204,533,632...204,546,843
JBrowse link
G Ttc37 tetratricopeptide repeat domain 37 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of TTC37 mRNA CTD PMID:19074003 NCBI chr 2:5,631,544...5,783,643
Ensembl chr 2:5,631,635...5,751,626
JBrowse link
G Ubap1 ubiquitin-associated protein 1 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of UBAP1 mRNA CTD PMID:19074003 NCBI chr 5:56,520,722...56,561,153
Ensembl chr 5:56,520,743...56,561,152
JBrowse link
G Ube2d3 ubiquitin-conjugating enzyme E2D 3 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of UBE2D3 mRNA CTD PMID:19074003 NCBI chr 2:223,868,397...223,899,606
Ensembl chr 2:223,868,730...223,898,081
JBrowse link
G Vcam1 vascular cell adhesion molecule 1 multiple interactions ISO [Ethinyl Estradiol co-treated with Levonorgestrel] results in decreased expression of VCAM1 protein CTD PMID:15769986 NCBI chr 2:204,038,120...204,057,852
Ensembl chr 2:204,038,114...204,057,958
JBrowse link
G Vdr vitamin D receptor multiple interactions ISO VDR gene polymorphism affects the reaction [[Ethinyl Estradiol co-treated with Levonorgestrel] affects the expression of ALPL protein]; VDR gene polymorphism affects the reaction [[Ethinyl Estradiol co-treated with Levonorgestrel] affects the expression of BGLAP protein] CTD PMID:12521655 NCBI chr 7:128,987,981...129,037,677
Ensembl chr 7:128,987,981...129,037,677
JBrowse link
G Vegfa vascular endothelial growth factor A increases expression ISO Levonorgestrel results in increased expression of VEGFA mRNA; Levonorgestrel results in increased expression of VEGFA mRNA alternative form CTD PMID:17010073 NCBI chr 9:14,955,300...14,970,641
Ensembl chr 9:14,955,300...14,970,641
JBrowse link
G Xylt1 xylosyltransferase 1 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of XYLT1 mRNA CTD PMID:19074003 NCBI chr 1:171,643,925...171,929,774
Ensembl chr 1:171,643,925...171,926,783
JBrowse link
G Yeats2 YEATS domain containing 2 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of YEATS2 mRNA CTD PMID:19074003 NCBI chr11:80,743,134...80,829,253
Ensembl chr11:80,743,134...80,829,208
JBrowse link
G Zcchc7 zinc finger CCHC-type containing 7 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of ZCCHC7 mRNA CTD PMID:19074003 NCBI chr 5:58,992,558...59,173,308
Ensembl chr 5:58,993,290...59,173,300
JBrowse link
G Zeb2 zinc finger E-box binding homeobox 2 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of ZEB2 mRNA CTD PMID:19074003 NCBI chr 3:29,219,765...29,342,094
Ensembl chr 3:29,218,301...29,345,157
JBrowse link
G Zfand6 zinc finger AN1-type containing 6 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of ZFAND6 mRNA CTD PMID:19074003 NCBI chr 1:138,581,002...138,652,052
Ensembl chr 1:138,581,002...138,651,939
JBrowse link
G Zfp518a zinc finger protein 518A multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of ZNF518A mRNA CTD PMID:19074003 NCBI chr 1:239,719,305...239,744,978
Ensembl chr 1:239,719,505...239,744,979
JBrowse link
G Zfp638 zinc finger protein 638 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of ZNF638 mRNA CTD PMID:19074003 NCBI chr 4:116,355,934...116,479,845
Ensembl chr 4:116,402,428...116,479,845
JBrowse link
G Zfr zinc finger RNA binding protein multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in decreased expression of ZFR mRNA CTD PMID:19074003 NCBI chr 2:61,137,611...61,200,322
Ensembl chr 2:61,137,611...61,200,322
JBrowse link
G Zkscan7 zinc finger with KRAB and SCAN domains 7 multiple interactions ISO [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of ZKSCAN7 mRNA CTD PMID:19074003 NCBI chr 8:122,501,938...122,519,600
Ensembl chr 8:122,502,218...122,519,600
JBrowse link

Term paths to the root
Path 1
Term Annotations click to browse term
  CHEBI ontology 19812
    chemical entity 19812
      group 19733
        organic group 18728
          3-oxo-Delta(4)-steroid group 8423
            3-oxo-Delta(4) steroid 8423
              levonorgestrel 198
Path 2
Term Annotations click to browse term
  CHEBI ontology 19812
    subatomic particle 19811
      composite particle 19811
        hadron 19811
          baryon 19811
            nucleon 19811
              atomic nucleus 19811
                atom 19811
                  main group element atom 19708
                    p-block element atom 19708
                      carbon group element atom 19630
                        carbon atom 19620
                          organic molecular entity 19620
                            organic group 18728
                              organic divalent group 18719
                                organodiyl group 18719
                                  carbonyl group 18667
                                    carbonyl compound 18667
                                      ketone 16924
                                        oxo steroid 9718
                                          3-oxo steroid 9281
                                            3-oxo-Delta(4) steroid 8423
                                              norgestrel 198
                                                levonorgestrel 198
paths to the root